Literature DB >> 3919892

[Monoclonal antibody analysis of human pancreatic juice components related to the pancreatic calculi protein].

G Montalto, M Lusher, A De Caro, L Multigner, H Sarles, M Delaage.   

Abstract

A CaCO3-crystal growth inhibitor has recently been isolated from the calculi of patients affected by pancreatic lithiasis. It is a phosphoglycoprotein, with a molecular weight of 14,000, whose probable physiological role is the stabilization of exocrine pancreatic secretion which is supersaturated with respect to CaCO3. In order to isolate this inhibitor from human pancreatic juice, monoclonal antibodies to the protein were prepared and an immunoadsorbent column was developed. Sodium dodecyl sulphate-polyacrylamide gel electrophoresis of proteins fixed by the immunoadsorbent reveals the form having a molecular weight of 14,000, in addition to other protein bands which have higher molecular weights (16,000, 16,800, 18,000, and 18,800). All of these different proteins are also recognized by a monospecific polyclonal antibody to the 14,000 molecular weight form. Using the same monospecific polyclonal antibody only one messenger RNA coding for this inhibitor has been demonstrated. Thus, this heterogeneity might be explained by post-translational modifications.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3919892

Source DB:  PubMed          Journal:  C R Acad Sci III        ISSN: 0764-4469


  5 in total

1.  Pancreatic stone protein. What is it and what does it do?

Authors:  K N Rao; D H Van Thiel
Journal:  Dig Dis Sci       Date:  1991-11       Impact factor: 3.199

2.  Partial amino acid sequence of human pancreatic stone protein, a novel pancreatic secretory protein.

Authors:  G Montalto; J Bonicel; L Multigner; M Rovery; H Sarles; A De Caro
Journal:  Biochem J       Date:  1986-08-15       Impact factor: 3.857

3.  The immunohistochemical evaluation of PSP/reg-protein in normal and diseased human pancreatic tissues.

Authors:  Y Satomura; N Sawabu; H Ohta; H Watanabe; O Yamakawa; Y Motoo; T Okai; D Toya; H Makino; H Okamoto
Journal:  Int J Pancreatol       Date:  1993-02

4.  Measurement of serum PSP/reg-protein concentration in various diseases with a newly developed enzyme-linked immunosorbent assay.

Authors:  Y Satomura; N Sawabu; I Mouri; O Yamakawa; H Watanabe; Y Motoo; T Okai; T Ito; K Kaneda; H Okamoto
Journal:  J Gastroenterol       Date:  1995-10       Impact factor: 7.527

5.  Quantification of human lithostathine by high performance liquid chromatography.

Authors:  J P Bernard; M Barthet; B Gharib; R Michel; A Lilova; J Sahel; J C Dagorn; M De Reggi
Journal:  Gut       Date:  1995-04       Impact factor: 23.059

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.